Component

Rat experimental hyperalgesia

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. The PAT analogue reduced experimental hyperalgesia in rats with changes in inflammatory mediators; this is not native-thymulin analgesic efficacy in humans.

    Experimental context and source evidence
    evidence_access
    Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.
    experimental_contrast
    {"intervention": "PAT analogue", "comparator": "Experimental control", "endpoint": "The PAT analogue reduced experimental hyperalgesia in rats with changes in inflammatory mediators; this is not native-thymulin analgesic efficacy in humans.", "effect_direction": "decrease", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.
    experimental_model
    Rat PAT experiment; analogue kept separate from native peptide and withdrawn hippocampal PAT article.
    interpretation_status
    Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
    limitations
    Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.
    plain_language
    The PAT analogue reduced experimental hyperalgesia in rats with changes in inflammatory mediators; this is not native-thymulin analgesic efficacy in humans.
    primary_references
    Potent analgesic and anti-inflammatory actions of a novel thymulin-related peptide in the rat. | 2002 | DOI 10.1038/sj.bjp.0704793 | PMID 12110619 | https://pubmed.ncbi.nlm.nih.gov/12110619/
    source_locator
    Reviewed reference lines 150-150; exact primary location described in quoted passage where extracted.

    Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 150–150

    Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Rat PAT experiment; analogue kept separate from native peptide and withdrawn hippocampal PAT article. · Recorded from source · Recorded from source

    Native peptide, zinc-loaded preparation, engineered met-FTS expression, PAT and nanoparticles are separate interventions. The PAT rat study supports anti-hyperalgesic activity for that **analogue**, with changes in inflammatory mediators; it does not establish analgesic efficacy of native thymulin in people. [PAT study](https://pubmed.ncbi.nlm.nih.gov/12110619/)
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.